Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures
The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Abstract
Background Previous studies have shown that alendronate can increase bone mineral density (BMD) and prevent radiographically defined (morphometric) vertebral fractures. The Fracture Intervention Trial aimed to investigate the effect of alendronate on the risk of morphometric as well as clinically evident fractures in postmenopausal women with low bone mass. Methods Women aged 55-81 with low femoral-neck BMD were enrolled in two study groups based on presence or absence of an existing vertebral fracture. Results for women with at least one vertebral fracture at baseline are reported here. 2027 women were randomly assigned placebo (1005) or alendronate (1022) and followed up for 36 months. The dose of alendronate (initially 5 mg daily) was increased (to 10 mg daily) at 24 months, with maintenance of the double blind. Lateral spine radiography was done at baseline and at 24 and 36 months. New vertebral fractures, the primary endpoint, were defined by morphometry as a decrease of 20% (and at least 4 mm) in at least one vertebral height between the baseline and latest follow-up radiograph. Non-spine clinical fractures were confirmed by radiographic reports. New symptomatic vertebral fractures were based on self-report and confirmed by radiography. Findings Follow-up radiographs were obtained for 1946 women (98% of surviving participants). 78 (8.0%) of women in the alendronate group had one or more new morphometric vertebral fractures compared with 145 (15.0%) in the placebo group…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“There are abundant data that patients with spine and hip fractures will have reduced fracture risk if treated with pharmacologic therapy.”
From Clinician’s Guide to Prevention and Treatment of Osteoporosis (2014) · cites this paper as [49]
In the citing paper
“This is true for fracture patients with BMD in both the low bone mass and osteoporosis range [49–58].”
From Clinician’s Guide to Prevention and Treatment of Osteoporosis (2014) · cites this paper as [49]
In the citing paper
“Alendronate reduces the incidence of spine and hip fractures by about 50 % over 3 years in patients with a prior vertebral fracture or in patients who have osteoporosis at the hip site [49, 59].”
From Clinician’s Guide to Prevention and Treatment of Osteoporosis (2014) · cites this paper as [49]
Citations
Cites
Cox, D. R., & Oakes, D. (2018) · Chapman & Hall/CRC eBooks · doi:10.1201/9781315137438 · Cited by 6,234
Breslow, N., Cox, D. R., & Oakes, D. (1985) · Biometrics · doi:10.2307/2530888 · Cited by 4,333
Vertebral fracture assessment using a semiquantitative technique
Genant, H. K., Wu, C. Y., van Kuijk, C., & Nevitt, M. C. (1993) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650080915 · Cited by 3,691
Self-citationHip fractures in the elderly: A world-wide projection
Cooper, C., Campion, G., & Melton, L. J. (1992) · Osteoporosis International · doi:10.1007/bf01623184 · Cited by 3,213
Vitamin D3and Calcium to Prevent Hip Fractures in Elderly Women
Chapuy, M. C., Arlot, M. E., Duboeuf, F., Brun, J., Crouzet, B., Arnaud, S., Delmas, P. D., & Meunier, P. J. (1992) · New England Journal of Medicine · doi:10.1056/nejm199212033272305 · Cited by 2,950
Hormone Therapy To Prevent Disease and Prolong Life in Postmenopausal Women
Grady, D., Rubin, S. M., Petitti, D. B., Fox, C. S., Black, D., Ettinger, B., Ernster, V. L., & Cummings, S. R. (1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-117-12-1016 · Cited by 2,336
Self-citationLiberman, U. A., Weiss, S. R., Bröll, J., Minne, H. W., Quan, H., Bell, N. H., Rodriguez-Portales, J., Downs, R. W., Dequeker, J., Favus, M., et al. (1995) · New England Journal of Medicine · doi:10.1056/nejm199511303332201 · Cited by 2,288
Self-citationPre-Existing Fractures and Bone Mass Predict Vertebral Fracture Incidence in Women
Ross, P. D., Davis, J. W., Epstein, R. S., & Wasnich, R. D. (1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-114-11-919 · Cited by 1,107
Intermittent Cyclical Etidronate Treatment of Postmenopausal Osteoporosis
Watts, N. B., Harris, S. T., Genant, H. K., Wasnich, R. D., Miller, P. D., Jackson, R. D., Licata, A. A., Ross, P., Woodson, G. C., Yanover, M. J., et al. (1990) · New England Journal of Medicine · doi:10.1056/nejm199007123230201 · Cited by 949
Self-citationStorm, T., Thamsborg, G., Steiniche, T., Genant, H. K., & Sorensen, O. H. (1990) · New England Journal of Medicine · doi:10.1056/nejm199005033221803 · Cited by 935
Self-citationEPIDEMIOLOGY OF VERTEBRAL FRACTURES IN WOMEN
MELTON, L. J., KAN, S. H., FRYE, M. A., WAHNER, H. W., O'FALLON, W. M., & RIGGS, B. L. (1989) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a115204 · Cited by 924
Treatment of Postmenopausal Osteoporosis with Transdermal Estrogen
Lufkin, E. G., Wahner, H. W., O'Fallon, W. M., Hodgson, S. F., Kotowicz, M. A., Lane, A. W., Judd, H. L., Caplan, R. H., & Riggs, B. L. (1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-117-1-1 · Cited by 810
The Prevention and Treatment of Osteoporosis
Wood, A. J. J., Riggs, B. L., & Melton, L. J. (1992) · New England Journal of Medicine · doi:10.1056/nejm199208273270908 · Cited by 754
Cummings, S. R. (1989) · Archives of Internal Medicine · doi:10.1001/archinte.149.11.2445 · Cited by 699
Self-citationHip Fracture and the Use of Estrogens in Postmenopausal Women
Kiel, D. P., Felson, D. T., Anderson, J. J., Wilson, P. W. F., & Moskowitz, M. A. (1987) · New England Journal of Medicine · doi:10.1056/nejm198711053171901 · Cited by 632
Hip Fracture and the Use of Estrogens in Postmenopausal Women: The Framingham Study
KIEL, D. P., FELSON, D. T., ANDERSON, J. J., WILSON, P. W. F., & MOSKOWITZ, M. A. (1988) · Obstetrical & Gynecological Survey · doi:10.1097/00006254-198807000-00018 · Cited by 625
Treatment of Postmenopausal Osteoporosis with Calcitriol or Calcium
Tilyard, M. W., Spears, G. F. S., Thomson, J., & Dovey, S. (1992) · New England Journal of Medicine · doi:10.1056/nejm199202063260601 · Cited by 575
Which Fractures Are Associated with Low Appendicular Bone Mass in Elderly Women?
Seeley, D. G., Browner, W. S., Nevitt, M. C., Genant, H. K., Scott, J. C., Cummings, S. R., & Study of Osteoporotic Fractures Research Group (1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-115-11-837 · Cited by 558
Self-citationRiggs, B. L., Seeman, E., Hodgson, S. F., Taves, D. R., & O'Fallon, W. M. (1982) · New England Journal of Medicine · doi:10.1056/nejm198202253060802 · Cited by 557
Overgaard, K., Hansen, M. A., Jensen, S. B., & Christiansen, C. (1992) · BMJ · doi:10.1136/bmj.305.6853.556 · Cited by 426
Harris, S. T., Watts, N. B., Jackson, R. D., Genant, H. K., Wasnich, R. D., Ross, P., Miller, P. D., Licata, A. A., & Chesnut, C. H. (1993) · The American Journal of Medicine · doi:10.1016/0002-9343(93)90350-x · Cited by 354
Self-citationEVALUATION OF TWO FOOD FREQUENCY METHODS OF MEASURING DIETARY CALCIUM INTAKE
CUMMINGS, S. R., BLOCK, G., McHENRY, K., & BARON, R. B. (1987) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a114716 · Cited by 296
Self-citationBlack, D. M., Palermo, L., Nevitt, M. C., Genant, H. K., Epstein, R., Valentin, R. S., & Cummings, S. R. (1995) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650100610 · Cited by 253
Self-citationPak, C. Y. C., Sakhaee, K., Adams-Huet, B., Piziak, V., Peterson, R. D., & Poindexter, J. R. (1995) · Annals of Internal Medicine · doi:10.7326/0003-4819-123-6-199509150-00001 · Cited by 241
Report assessing vertebral fractures
R., S. (1995) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650100403 · Cited by 240
Femoral bone loss progresses with age: A longitudinal study in women over age 65
Greenspan, S. L., Maitland, L. A., Myers, E. R., Krasnow, M. B., & Kido, T. H. (1994) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650091216 · Cited by 180
Design of the Fracture Intervention Trial
Black, D. M., Reiss, T. R., Nevitt, M. C., Cauley, J., Karpf, D., Cummings, S. R., & the Fracture Intervention Trial Research Group (1993) · Osteoporosis International · doi:10.1007/bf01623005 · Cited by 174
Self-citationRisk of hip fracture in women with vertebral fracture
Kotowicz, M. A., Melton, L. J., Cooper, C. C., Atkinson, E. J., O’Fallon, W. M., & Riggs, B. L. (1994) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650090503 · Cited by 137
Risk of hip fracture among women with vertebral fractures
Kotowicz, M. A., Melton, L. J., Cedel, S. L., O’Fallon, W. M., & Riggs, B. L. (1990) · Bone and Mineral · doi:10.1016/0169-6009(90)90284-m · Cited by 131
Vertebral Fracture in Osteoporosis
Suk, S. I., Lee, C., Kang, H. S., Lee, J. H., 민학진, Cha, S. H., & Chung, Y. J. (1993) · The Journal of the Korean Orthopaedic Association · doi:10.4055/jkoa.1993.28.3.980 · Cited by 110
Cooper, C., & Melton, L. J. (1992) · BMJ · doi:10.1136/bmj.304.6830.793 · Cited by 99
Liberman, U. A., Weiss, S. R., Broll, J., Minne, H. W., Quan, H., Bell, N. H., Rodriguez-Portales, J., Downs, R. W., Dequeker, J., Favus, M., et al. (1996) · Obstetrical & Gynecological Survey · doi:10.1097/00006254-199604000-00018 · Cited by 76
Self-citationEffect of radiographic abnormalities on rate of bone loss from the spine
Dawson-Hughes, B. F., & Dallal, G. E. (1990) · Calcified Tissue International · doi:10.1007/bf02555008 · Cited by 70
Al‐Azzawi, F., Hart, D., & Lindsay, R. S. (1987) · BMJ · doi:10.1136/bmj.294.6582.1261-a · Cited by 63
Cited by
Neer, R. M., Arnaud, C. D., Zanchetta, J. R., Prince, R., Gaich, G. A., Reginster, J.-Y., Hodsman, A. B., Eriksen, E. F., Ish-Shalom, S., Genant, H. K., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200105103441904 · Cited by 4,602
Self-citationClinician’s Guide to Prevention and Treatment of Osteoporosis
Cosman, F., de Beur, S. J., LeBoff, M. S., Lewiecki, E. M., Tanner, B., Randall, S., & Lindsay, R. (2014) · Osteoporosis International · doi:10.1007/s00198-014-2794-2 · Cited by 4,149
Denosumab for Prevention of Fractures in Postmenopausal Women with Osteoporosis
Cummings, S. R., Martin, J. S., McClung, M. R., Siris, E. S., Eastell, R., Reid, I. R., Delmas, P., Zoog, H. B., Austin, M., Wang, A., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0809493 · Cited by 3,489
Self-citationEttinger, B. (1999) · JAMA · doi:10.1001/jama.282.7.637 · Cited by 3,366
Self-citationOnce-Yearly Zoledronic Acid for Treatment of Postmenopausal Osteoporosis
Black, D. M., Delmas, P. D., Eastell, R., Reid, I. R., Boonen, S., Cauley, J. A., Cosman, F., Lakatos, P., Leung, P. C., Man, Z., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa067312 · Cited by 2,986
Self-citation
Metadata
- Authors
- Black, D. M., Cummings, S. R., Karpf, D. B., Cauley, J. A., Thompson, D. E., Nevitt, M. C., Bauer, D. C., Genant, H. K., Haskell, W. L., Marcus, R., Ott, S. M., Torner, J. C., Quandt, S. A., Reiss, T. F., & Ensrud, K. E.
- Affiliations
- University of California, San Francisco (US)
- Merck & Co., Inc., Rahway, NJ, USA (United States) (US)
- University of Pittsburgh (US)
- Stanford University (US)
- VA Palo Alto Health Care System (US)
- University of Washington (US)
- University of Iowa (US)
- Wake Forest University (US)
- University of Minnesota (US)
- Corresponding author
- Black, Dennis M
- ORCID
- Venue
- The Lancet
- Publisher
- Elsevier BV
- Published
- 1996-12
- Volume
- 348
- Issue
- 9041
- Pages
- 1535-1541
- ISSN
- 0099-5355 (ISSN-L)
- 0140-6736
- OpenAlex
- W2153009489
- Cited by
- 3,846
- References
- 34
- Citations by year
- 2026: 37 · 2025: 67 · 2024: 52 · 2023: 61 · 2022: 67 · 2021: 82 · 2020: 95 · 2019: 75 · 2018: 88 · 2017: 88 · 2016: 100 · 2015: 123 · 2014: 135 · 2013: 160 · 2012: 154
- FWCI
- 124.37
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- Locations
- The Lancet (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Neurological Disorders and Stroke (R01NS048597)
- Topics
- Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone health and osteoporosis research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Menopause: Health Impacts and Treatments
- Health Sciences › Medicine › Oncology › Bone health and treatments
- Keywords
- alendronate, bisphosphonates, vertebral fractures, postmenopausal women, osteoporosis, fracture risk, hip fracture, wrist fractures, femoral neck bone mineral density, osteopenia, Fracture Intervention Trial, bone mineral density, fracture prevention, treatment discontinuation, adverse effects, drug safety, cost-effectiveness, quality of life
- MeSH terms
- Aged, Aged, 80 and over, Female, Femur Neck, Follow-Up Studies, Hip Fractures, Humans, Middle Aged, Radiography, Risk, Bone Density, Osteoporosis, Postmenopausal, Spinal Fractures, Alendronate, Fractures, Bone
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.